AnaptysBio (@AnaptysBio) header
AnaptysBio (@AnaptysBio) profile picture

AnaptysBio

@AnaptysBio

Clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics. $ANAB

 San Diego, CA
anaptysbio.com
Joined October 2011
  • Tweets183
  • Following26
  • Followers501
64Media
Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)Photo by AnaptysBio (@AnaptysBio)
Congratulations to @AnaptysBio for their fundraising and participation in this year’s National Psoriasis Foundation Walk in San Diego, which raises funds for psoriatic disease. Innovaderm is proud to have donated too, as this is a cause we have stood behind since our inception.
Image from Indero (formerly Innovaderm) (@InderoCRO)
2
1
Congrats to Magda Marquet, who was appointed to California-based @AnaptysBio (NASDAQ:ANAB) Board of Directors. We applaud @AnaptysBio's Board in recognizing the business & social imperative of Latino/a board leadership. #DiversityIncludesLatinos #CorpGov
Image from Latino Directors (@LatinoDirectors)
2
1
6
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria1316 Dec 2020
Our VP Mol Bio & Protein Science, Dr. Stephen Parmley, will present @AnaptysBio's therapeutic antibody platform, which mimics natural maturation by coupling somatic hypermutation with mammalian cell display, at the 2020 Antibody Eng & Therapeutics Conference tomorrow. $ANAB
1
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria137 Nov 2020
Proud to deliver opening remarks virtually at @NPF annual walk earlier today. @AnaptysBio employees continue to raise money and awareness in support of patients suffering with inflammatory diseases. $ANAB
1
2
Replying to @AnaptysBio
@AnaptysBio’s Marily Kehry, Vice President of Cell and Functional Biology will be speaking across numerous platforms at #FestOfBiologics View the full 2019 agenda here bit.ly/2Cn3YgK
Image from Total BioPharma (@totalbiopharma)
2
1
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria1312 Feb 2019
Replying to @LifeSciVC
Thanks @LifeSciVC
Image from Hamza Suria (@hsuria13)
1
1
3
.@AnaptysBio lead IL-33 antibody cleared a midstage test in asthma this past September. Don't miss hearing more from their President & CEO @hsuria13 at #EASTWESTCEO where he'll talk about Early Stage #Biotech Strategies for Survival. ir.anaptysbio.com/news-relea…
Image from LeadingBiotech (@LeadingBiotech)
3
4
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria1315 Oct 2018
Elevated levels of interleukin‐33 are associated with allergic and eosinophilic asthma onlinelibrary.wiley.com/doi/… $anab #etokimab

Elevated levels of interleukin‐33 are associated with allergic and eosinophilic asthma

IL-33 is a recently discovered cytokine which plays an important role in asthma pathogenesis. Aim To evaluate serum IL-33 in patients with asthma and healthy controls, and to evaluate the associati...

onlinelibrary.wiley.com
2
1
#DYK that the number 2 top performing IPO this year is a San Diego #biotech company? @AnaptysBio #SDlifechanging #JLABSSD
Image from Brittney Sabbah (@BritSab09)
1
5
9
With just a little encouragement, biotech investors are ready to fall in love again $ANAB +101% endpts.com/with-just-a-littl…
With just a little encouragement, biotech investors are ready to fall in love again

With just a little encouragement, biotech investors are ready to fall in love again

While you may have dealt with VCs during your pre-IPO life, public investors are a whole new level of scrutiny. Of course your development programs need ...

endpoints.news
5
1
9
Candid Truths From A Biotech #IPO -- A Biotech Voices column from AnaptysBio CEO Hamza Suria. $ANAB endpts.com/candid-truths-fro…
2
13
3
17
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria1314 Mar 2017
IL-33 mutations can protect humans from asthma. Supports rationale for ANB020 in eosinophilic asthma. $ANAB nitter.gq/manuelrivascruz/status…
1
A huge congrats to @AnaptysBio one of our portfolio companies for their successful IPO last week! #UCLAVentures bit.ly/2koqU73
2
3
A big Nasdaq welcome to @AnaptysBio, congratulations on your #IPO! $ANAB
Image from Nasdaq Exchange (@NasdaqExchange)
9
1
10
AnaptysBio retweeted
Biocom (@Biocom) profile picture
Biocom
@Biocom26 Jan 2017
Way to go @AnaptysBio! First biotech co. to go public this year and $75M in IPO! buff.ly/2k6n9Tf
8
7
AnaptysBio retweeted
Xconomy (@Xconomy) profile picture
Xconomy@Xconomy26 Jan 2017
.@AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut | xconomy.com/san-diego/2017/0…
2
2
AnaptysBio retweeted
Hamza Suria (@hsuria13) profile picture
Hamza Suria@hsuria1310 Mar 2016
AnaptysBio Announces First-In-Human Dosing of Anti-IL-33 Antibody. anaptysbio.com/anaptysbio-an…
1
1
4
AnaptysBio retweeted
Xconomy (@Xconomy) profile picture
Xconomy@Xconomy16 May 2013
San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies | xconomy.com/san-diego/2013/0… @AnaptysBio
3
Load more